HighTower Advisors »

Terns Pharmaceuticals shares owned by HighTower Advisors

Quarter-by-quarter ownership of Terns Pharmaceuticals (TERN) shares owned by HighTower Advisors from 13F filings

Historical chart of HighTower Advisors investment in Terns Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Terns Pharmaceuticals held by HighTower Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Terns Pharmaceuticals by HighTower Advisors

Quarter filed Position value Share count Share price at filing
2024-12-31 $468k 84k 5.54

More positions owned by HighTower Advisors

Apple (AAPL)
Microsoft Corporation (MSFT)
Ishares Tr Core S&p500 Etf (IVV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
NVIDIA Corporation (NVDA)
Berkshire Hathaway Inc Del Cl A (BRK.A)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Exxon Mobil Corporation (XOM)
JPMorgan Chase & Co. (JPM)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Broadcom (AVGO)
Vanguard Index Fds Growth Etf (VUG)

View all positions for HighTower Advisors

Top funds holding Terns Pharmaceuticals

Soleus Capital Management
OrbiMed Advisors
Deep Track Capital
Morgan Stanley
Vivo Capital
Commodore Capital
BlackRock
Vanguard Group
Adage Capital Partners GP
Candriam Luxembourg S.C.A.
Acorn Capital Advisors
Schonfeld Strategic Advisors
Geode Capital Management
Citadel Advisors
State Street Corporation

View all funds holding Terns Pharmaceuticals